Minoru Ko is listed as an executive officer and director on 10 SEC Form D filings by 2 issuers between Apr 2012 and Nov 2025: ELIXIRGEN THERAPEUTICS, INC. (Baltimore, MD — biotechnology — 2018–2025; $7M reported sold to 3 investors) and Elixirgen, LLC (Baltimore, MD — biotechnology — 2012; $300K reported sold to 3 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $7.3M sold in total.
Listed alongside AKIHIRO KO (9 shared filings), HIROAKI KOBAYASHI (6 shared filings), SHAUNA CALLAHAN (6 shared filings), THOMAS WHITE (6 shared filings), JEFFREY CLELAND (4 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Minoru. Each name links to their own page.
All 2 issuers belong to the sponsor group Elixirgen (2 issuers, $4.3M reported sold, 2012–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Elixirgen has 2 companies on file and $4.3M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for Minoru Ko and found 10 differences: Minoru Ko appears on 1 deal that stopped filing before reaching its target; Form D filed 22 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.